Literature DB >> 30046520

Evaluation of a rat meibomian gland dysfunction model induced by closure of meibomian gland orifices.

Zi-Yi Dong1, Ming Ying2, Jie Zheng1, Lan-Jun Hu1, Jiang-Yan Xie1, Yi Ma1.   

Abstract

AIM: To find a stable, inexpensive, and reliable method to produce a rat meibomian gland dysfunction (MGD) model.
METHODS: We inserted slim guidewires into the meibomian gland orifices of twelve Brown Norway rats and fulgurized every guidewire to destroy part of the meibomian gland. We then observed the morphological changes in the eyelid margin, and compared the data of tear breakup time (TBUT), Schirmer I test, and the corneal fluorescence staining scores at different times (1, 2, 4, and 6wk). We observed pathological changes of the cornea, conjunctiva and meibomian gland, and we used real-time polymerase chain reaction to analyze epithelial growth factor (EGF), interleukin-6 (IL-6), IL-8, tumor necrosis factor-α (TNF-α), and Ki67.
RESULTS: In the fourth week, compared with the control group, the TBUT of the model group began to decreased (P<0.05). The tear secretion remained stable (P>0.05). The corneal dots were significantly increased in the fourth week when the fusion stain began to appear (P<0.05). In the fourth week, partial meibomian gland openings had hoary secretions blocked, orifices were expanded, and there was a partial convex deformation. In the sixth week, the tissue section showed that the number of conjunctival goblet cells was decreased, epithelial cells were irregular, the epithelium was detached and rough, and meibomian glands were lost. The expressions of EGF, IL-6, IL-8, and TNF-α in corneal, conjunctival, and meibomian tissues were highly increased (P<0.05), but no statistical difference was found in the expression of Ki67 in corneal and conjunctival tissues (P>0.05).
CONCLUSION: The MGD rat model, produced via electrocauterization of meibomian gland orifices, matched clinical manifestations and cytokine levels. Our research provides a new method of achieving an MGD animal model.

Entities:  

Keywords:  Ki67; animal model; epithelial growth factor; interleukin-6; interleukin-8; meibomian gland dysfunction; tumor necrosis factor-α

Year:  2018        PMID: 30046520      PMCID: PMC6048323          DOI: 10.18240/ijo.2018.07.01

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  30 in total

1.  Depression, Stress, Quality of Life, and Dry Eye Disease in Korean Women: A Population-Based Study.

Authors:  Kyung-Sun Na; Kyungdo Han; Yong-Gyu Park; Chul Na; Choun-Ki Joo
Journal:  Cornea       Date:  2015-07       Impact factor: 2.651

2.  Prevalence of and risk factors for symptomatic dry eye disease in Singapore.

Authors:  Li Li Tan; Philip Morgan; Zhi Qiang Cai; Robert A Straughan
Journal:  Clin Exp Optom       Date:  2014-09-30       Impact factor: 2.742

3.  Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model.

Authors:  Lidia Cocho; Itziar Fernández; Margarita Calonge; Verónica Martínez; María J González-García; Dolores Caballero; Lucía López-Corral; Carmen García-Vázquez; Lourdes Vázquez; Michael E Stern; Amalia Enríquez-de-Salamanca
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-02       Impact factor: 4.799

4.  A role for ELOVL4 in the mouse meibomian gland and sebocyte cell biology.

Authors:  Anne McMahon; Hua Lu; Igor A Butovich
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-01       Impact factor: 4.799

5.  Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1.

Authors:  M C Jong; M J Gijbels; V E Dahlmans; P J Gorp; S J Koopman; M Ponec; M H Hofker; L M Havekes
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

6.  Association between high tear epidermal growth factor levels and corneal subepithelial fibrosis in dry eye conditions.

Authors:  Kavita Rao; William J Farley; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-08       Impact factor: 4.799

7.  Age-related changes in the meibomian gland.

Authors:  Chyong Jy Nien; Jerry R Paugh; Salina Massei; Andrew J Wahlert; Winston W Kao; James V Jester
Journal:  Exp Eye Res       Date:  2009-09-04       Impact factor: 3.467

8.  Absence of ductal hyper-keratinization in mouse age-related meibomian gland dysfunction (ARMGD).

Authors:  Geraint J Parfitt; Yilu Xie; Mikhail Geyfman; Donald J Brown; James V Jester
Journal:  Aging (Albany NY)       Date:  2013-11       Impact factor: 5.682

Review 9.  Dry eye: an inflammatory ocular disease.

Authors:  Michelle Hessen; Esen Karamursel Akpek
Journal:  J Ophthalmic Vis Res       Date:  2014-04

10.  Oxidative stress induced age dependent meibomian gland dysfunction in Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice.

Authors:  Osama M A Ibrahim; Murat Dogru; Yukihiro Matsumoto; Ayako Igarashi; Takashi Kojima; Tais Hitomi Wakamatsu; Takaaki Inaba; Takahiko Shimizu; Jun Shimazaki; Kazuo Tsubota
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

View more
  2 in total

Review 1.  Meibomian Gland Dysfunction: What Have Animal Models Taught Us?

Authors:  Mingxia Sun; Isabel Y Moreno; Michelle Dang; Vivien J Coulson-Thomas
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

2.  Melatonin Attenuates LPS-Induced Proinflammatory Cytokine Response and Lipogenesis in Human Meibomian Gland Epithelial Cells via MAPK/NF-κB Pathway.

Authors:  Ren Liu; Jing Li; Yue Xu; Ziyan Chen; Huijing Ye; Jinhui Tang; Lai Wei; Lingyi Liang
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-05-02       Impact factor: 4.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.